Zacks.com on MSN

Recursion Pharmaceuticals (RXRX) Surges 8.2%: Is This an Indication of Further Gains?

Recursion Pharmaceuticals (RXRX) was a big mover last session on higher-than-average trading volume. The latest trend in ...

Evaluating Recursion After a 19% Rally Amid Renewed Interest in Biotech AI Initiatives

Thinking about what to do with Recursion Pharmaceuticals stock right now? You are not alone. In just the past week, the stock has jumped an impressive 19.2%, adding to an 18.5% surge over 30 days. It ...

Jim Cramer on Recursion: “I Need to See a Proof of Concept Here”

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks on Jim Cramer’s radar recently. When a caller asked about ...

I tested Claude 4.5 vs ChatGPT-5 with 9 tough prompts — and there's a clear winner

I tested Claude 4.5 against ChatGPT-5 in 9 challenges from logic puzzles to storytelling. Here’s which AI won.
eLife

Punctuated mutagenesis promotes multi-step evolutionary adaptation in human cancers

The rate of acquisition of genomic changes in cancer has been the topic of much discussion, with several recent investigations finding evidence of punctuated evolution instead of gradual accumulation ...